Epstein-Barr virus vaccine (MedImmune)

N/A

Report date: 2022/09/05 20:00:48

Base Information

Drug NameEpstein-Barr virus vaccine (MedImmune)

Drug Alias Name爱泼斯坦-巴尔病毒疫苗 - 葛兰素史克/MedImmune VaccinesRecombinant gp350 vaccine for infectious mononucleosisGSK Biologicals' EBV vaccine (268664)EBV vaccine 268664EBV gp350 +[8]

ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsEpstein-Barr Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMedimmune

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHenogen

Active IndicationsN/A

Inactive IndicationsEpstein-Barr Virus Infections

Other Information

ATC CodeN/A